138 related articles for article (PubMed ID: 36472509)
21. Safety of Metronidazole in Late Pre-term and Term Infants with Complicated Intra-abdominal Infections.
Commander SJ; Gao J; Zinkhan EK; Heresi G; Courtney SE; Lavery AP; Delmore P; Sokol GM; Moya F; Benjamin D; Bumpass TG; Debski J; Erinjeri J; Sharma G; Tracy ET; Smith PB; Cohen-Wolkowiez M; Hornik CP;
Pediatr Infect Dis J; 2020 Sep; 39(9):e245-e248. PubMed ID: 32453198
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibilities of specific syndromes created with organ-specific weighted incidence antibiograms (OSWIA) in patients with intra-abdominal infections.
Liu L; Ni Y
BMC Infect Dis; 2018 Nov; 18(1):584. PubMed ID: 30453893
[TBL] [Abstract][Full Text] [Related]
23. Essentials for selecting antimicrobial therapy for intra-abdominal infections.
Blot S; De Waele JJ; Vogelaers D
Drugs; 2012 Apr; 72(6):e17-32. PubMed ID: 22480338
[TBL] [Abstract][Full Text] [Related]
24. Fluoroquinolone-based versus β-lactam-based regimens for complicated intra-abdominal infections: a meta-analysis of randomised controlled trials.
Mavros MN; Theochari NA; Kyriakidou M; Economopoulos KP; Sava JA; Falagas ME
Int J Antimicrob Agents; 2019 Jun; 53(6):746-754. PubMed ID: 30639629
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic therapy in intra-abdominal infections--a review on randomised clinical trials.
Holzheimer RG; Dralle H
Eur J Med Res; 2001 Jul; 6(7):277-91. PubMed ID: 11485888
[TBL] [Abstract][Full Text] [Related]
26. Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia.
Tellor B; Skrupky LP; Symons W; High E; Micek ST; Mazuski JE
Surg Infect (Larchmt); 2015 Dec; 16(6):785-93. PubMed ID: 26258265
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Badal RE; Xu Y
Antimicrob Agents Chemother; 2016 Jan; 60(1):245-51. PubMed ID: 26482308
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
[TBL] [Abstract][Full Text] [Related]
29. Can Nasal Methicillin-Resistant Staphylococcus aureus Screening Be Used to Avoid Empiric Vancomycin Use in Intra-Abdominal Infection?
Hennessy SA; Shah PM; Guidry CA; Davies SW; Hranjec T; Sawyer RG
Surg Infect (Larchmt); 2015 Aug; 16(4):396-400. PubMed ID: 26069990
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis.
Khan S; Gupta DK; Khan DN
Kathmandu Univ Med J (KUMJ); 2005; 3(1):55-63. PubMed ID: 16401946
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic Use and Antimicrobial Resistance of Surgical Patients with Peritonitis at a Tertiary Referral Hospital in Rwanda.
Rickard J; Ngarambe C; Ndayizeye L; Smart B; Riviello R; Majyambere JP; Ghebre RG
Surg Infect (Larchmt); 2018; 19(4):382-387. PubMed ID: 29621001
[TBL] [Abstract][Full Text] [Related]
32. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Ohlin B; Cederberg A; Forssell H; Solhaug JH; Tveit E
Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of risk factors of intra-abdominal infection after surgery for colorectal cancer].
Jia L; Lu J; Ma X; Jiang H; Zhu Y; Liu Y; Cai Y; Zhang Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Apr; 19(4):409-13. PubMed ID: 27112474
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
Alvarez-Lerma F; Insausti-Ordeñana J; Jordá-Marcos R; Maraví-Poma E; Torres-Martí A; Nava J; Martínez-Pellús A; Palomar M; Barcenilla F;
Intensive Care Med; 2001 Mar; 27(3):493-502. PubMed ID: 11355117
[TBL] [Abstract][Full Text] [Related]
35. Optimal Antibiotic Duration for Bloodstream Infections Secondary to Intraabdominal Infection.
Patel K; Maguigan KL; Loftus TJ; Mohr AM; Shoulders BR
J Surg Res; 2021 Apr; 260():82-87. PubMed ID: 33326932
[TBL] [Abstract][Full Text] [Related]
36. Are We Hitting the Target?: The Effectiveness of Distinct Antibiotic Regimens in Pediatric Appendectomies.
Elrod J; Yarmal F; Mohr C; Dennebaum M; Boettcher M; Vincent D; Reinshagen K; Koenigs I
Pediatr Infect Dis J; 2022 Jun; 41(6):460-465. PubMed ID: 35333833
[TBL] [Abstract][Full Text] [Related]
37. Obesity Is Not Associated with Antimicrobial Treatment Failure for Intra-Abdominal Infection.
Dietch ZC; Duane TM; Cook CH; O'Neill PJ; Askari R; Napolitano LM; Namias N; Watson CM; Dent DL; Edwards BL; Shah PM; Guidry CA; Davies SW; Willis RN; Sawyer RG
Surg Infect (Larchmt); 2016 Aug; 17(4):412-21. PubMed ID: 27027416
[TBL] [Abstract][Full Text] [Related]
38. Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis.
Grau S; Lozano V; Valladares A; Cavanillas R; Xie Y; Nocea G
Appl Health Econ Health Policy; 2015 Aug; 13(4):369-79. PubMed ID: 25761545
[TBL] [Abstract][Full Text] [Related]
39. [Bacteriological profile and antibiotic treatment of postoperative peritonitis].
Missaoui K; Marzougui Y; Kouka J; Dhibi Y; Hannachi Z; Dziri C; Houissa M
Arch Inst Pasteur Tunis; 2014; 91(1-4):57-66. PubMed ID: 26485771
[TBL] [Abstract][Full Text] [Related]
40. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
Young M; Plosker GL
Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
